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Abstract This study explores the costs of non-malignant
chronic pain in patients awaiting treatment in a multidis-
ciplinary pain clinic in a hospital setting. Health care costs
due to chronic pain are particular high during the first year
after pain onset, and remain high compared with health
care costs before pain onset. The majority of chronic pain
patients incur the costs of alternative treatments. Chronic
pain causes production losses at work, as well as impair-
ment of non-work activities.
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Introduction
While the clinical effectiveness of multidisciplinary pain
management in chronic non-malignant pain patients has
been demonstrated in a number of studies [3, 9, 21], the
cost-effectiveness of multidisciplinary pain management
has not been determined, except in relation to multidisci-
plinary treatment in specific chronic pain patient groups
[16, 20].
Chronic pain management is typically facilitated in
multidisciplinary pain clinics in a hospital setting. Based
on heterogeneous pain pathophysiology and aetiology [2],
treatment at pain clinics consists of different combinations
of physical, psychological, educational, behavioural, and
cognitive interventions, and is adapted to the individual
patient. Generally, patients will have suffered from chronic
pain for several years before being referred to a clinic.
Often referral is not introduced before all other alternatives
have been shown unsuccessful [20].
Decision makers may consider the cost-effectiveness of
clinics, rather than the cost-effectiveness of treating specific
patient groups, e.g. patients with chronic low back pain,
when allocating resources. Whereas studies of the cost-
effectiveness of treatment targeted at specific patient groups
can be designed as traditional randomised controlled trials,
economic evaluation of multidisciplinary pain clinics
involves several methodological challenges since controlled
experiments may be difficult or even impossible to carry out.
The overall cost-effectiveness of an intervention can be
established in two ways. Firstly, the cost of intervention is
offset by reductions in other resource uses, leading to an
overall decline in the cost of pain management, together
with unaltered or improved patients health and well-being
in general. Secondly, the intervention may cause an
increase in costs together with an improvement in patient
health and well-being. That is to say, the cost of the
intervention is not offset by reductions in the use of other
resources. In that case, decision makers must decide whe-
ther additional costs are acceptable in relation to
improvement in patient health and well-being [6]. In the
latter case, intervention cost-effectiveness is based on
judgement.
Whether pain management in a multidisciplinary pain
clinic can reduce health care costs and other costs related to
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chronic pain may depend on several factors, for example
the extent to which the clinic can control or influence the
use of health care resources, e.g. hospitalisation. The
potential for cost savings as a result of multidisciplinary
pain management may also depend on resource use at the
onset of treatment in a pain clinic, i.e. the higher the health
care costs at the outset, the higher the potential for cutting
costs.
The aim of this study is to explore the costs of non-
malignant chronic pain in patients awaiting treatment in a
multidisciplinary pain clinic in a hospital setting.
Methods
Study design
The study was designed as a cross sectional study of
patients referred from general practice for treatment at a
multidisciplinary pain hospital clinic. We sampled all
patients on the waiting list for treatment at The Multi-
disciplinary Pain Clinic in Funen County at Odense
University Hospital by 1 December 2005. The target was
to include 200 patients in the study. Because it was not
possible to reach this target by that date, we included
patients referred to the clinic’s waiting list until 18 Jan-
uary 2006. Data were collected by a telephone interview
and mailed questionnaire. Inclusion of participants was
terminated when it was confirmed that 200 interviews had
been performed. The telephone interviews were structured
by a questionnaire, and carried out by personnel from the
Multidisciplinary Pain Clinic in Funen County at Odense
University Hospital experienced in contact with this
patient group. Patients that would have needed assistance
from an interpreter during a telephone interview, i.e.
patients that were not fluent in Danish, were excluded
from the sample.
From the referral notes, we collected information on
gender, date of birth and referral. The referral notes also
provided details of pain location, pain diagnosis and aeti-
ology. The data were merged with data from public
registers, including data on participant use of in- and out-
patient treatment and visits to hospital accident and
emergency wards. Public register data contains information
about all discharges of individual patients from publicly
owned hospitals, including outpatient visits and accident
and emergency department visits [1, 13]. All participant
records were extracted from 1 January 1996 to 31
December 2005.
Each discharge was classified in accordance with the
Danish Diagnosis Related Grouping (DRG) system [18].
Discharges before 2000, i.e. before the introduction of the
Danish DRG system, were classified according to the
system that applied for 2000. For discharges in 2001 and
later, the current DRG system was applied [19].
Data on the use of services delivered by general prac-
titioners and other medical specialists, dentists,
physiotherapists, chiropractors, chiropodists, and psycho-
logical counsellors was obtained from The National Health
Insurance Service Registry, which is a central register of
health care services covered by Danish national health
insurance [14]. The register contains information on ser-
vice type, cost and delivery date. All records covering the
same period as for hospital services were extracted from
the register.
Data on participants use of prescription drugs was col-
lected from a Danish prescription register, The Odense
University Pharmaco-epidemiological Database (OPED),
which is a register based on transaction reports from the
dispensing pharmacies in Funen County [10, 11]. The
transaction reports were identifiable from participant per-
sonal identification numbers. From each transaction report,
we extracted information on the date the prescription was
presented at the pharmacy, and the number, type and cost
of the medication(s) prescribed. We extracted data cover-
ing 1 January 1996 to 31 December 2005. Since OPED
covers the County of Funen, only data on participants
living in that county during this period was retrieved. Data
on over-the-counter medication was not available from
OPED.
Data on participant use of public sector health care
services was collected during the telephone interview.
Participants were asked whether they received assistance
with regard to personal care/hygiene and/or medication
administration due to their chronic pain diagnosis. They
were also asked whether they received assistance with
house cleaning, laundry or shopping (services that are
typically provided free of charge for chronically impaired
persons in Denmark). Participants reported the year in
which they began receiving these types of services. Finally,
participants were asked whether they had chosen to pay for
private house cleaning, gardening, and/or other services as
a result of chronic pain. Participants that had paid for
private services were asked to disclose their total expen-
ditures for the 6 month period prior to the interview.
In a mailed questionnaire, participants were asked
whether they had used alternative treatments, such as
homeopathy, reflexology, acupuncture, healing or hypno-
sis. Where relevant, participants were asked to disclose
their spending on alternative treatments.
Costs
The resource volumes were combined with unit costs to
obtain a cost per person. The unit costs were included as an
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approximation of the social opportunity cost of each item
[5]. All costs were measured in 2006 values of Danish
kroner (DKK). Where required, costs were converted to
2006 values using the official consumer price index pub-
lished by Statistics Denmark [17].
We used DRG charges as unit costs for hospital treat-
ment. DRG charges were provided by the Danish National
Board of Health. DRG charges reflect the average hospital
costs for treating patients with similar conditions and
processes of care. For patients staying beyond the number
of days covered by the DRG charge, an extra charge per
day for the excess number of days covered was added to
the hospital costs.
The unit costs of GP services and services from other
healthcare providers were based on the prevailing national
health insurance rate (data included the fee reimbursed at
the point of delivery and type of resource used). We added
patient co-payment for physiotherapy, chiropractic treat-
ment, and dental services as appropriate.
The prevailing package price for prescription drugs was
provided along with the data on prescription drug con-
sumption. The package price reflected the retail price,
which included the cost price for the pharmacy, the pre-
scription fee charged by the pharmacy and value added tax
before any reimbursement at the point of delivery. Thus,
the reported price covered the full product cost irrespective
of who incurred the cost.
Unit costs relating to personal care and practical assis-
tance in the home were collected from a national database
that collects information from every Danish municipality
regarding costs per hour for these services. Since they are
provided free of charge for the recipient, we assumed that
the unit cost of these services reflected the opportunity cost.
We used the unit cost applicable to the council where the
participant lived. As unit costs vary between municipality,
we analysed how different unit costs affected the results,
using the minimum and maximum observed unit costs of
213 and 334 DKK per hour, for sensitivity analysis.
In order to report annual costs, we multiplied the
reported resource use of personal and practical assistance
in the home by 12.
The costs of privately provided house cleaning, gar-
dening, and/or other services, as well as the costs of
alternative treatment were estimated on the basis of par-
ticipant expenditure on these services. That is to say, we
assumed that the full cost of these services and alternative
treatments was met by participants.
Productivity costs
Productivity costs were defined as costs due to lost or
impaired ability to work or to engage in leisure activities
due to chronic pain [12], i.e. the costs of lost production,
paid as well as unpaid.
We included a specific health problem version of the
work productivity and activity impairment (WPAI)
instrument in the postal questionnaire [15]. The WPAI
instrument was used to determine the extent of time lost
from work and productivity loss whilst at work due to
chronic pain in participants in the work force. It was also
used to determine the extent to which participants were
able to carry out regular daily activities, other than work at
a job such as housekeeping, or child caring (see Appendix).
All questions in the WPAI instrument related to the
preceding 7 days. The questions considered the number of
hours missed from work due to chronic pain, the number of
hours missed because of other reasons (such as time off or
holidays), hours actually worked and productivity while
working.
Productivity was measured using a scale ranging from
zero (chronic pain had no effect on work) to ten (chronic
pain completely prevented working). A similar rating scale
was used to assess participant ability to carry out regular
daily activities other than paid work.
For respondents that were working, we estimated the
percentage of work time missed due to chronic pain, the
percentage of impairment while working due to chronic
pain, and the percentage of overall work impairment due to
chronic pain. Work time was defined as the number of
hours participants actually worked or should have worked
if they had not missed work due to chronic pain. That is to
say, work time net of vacation, holidays and time off.
Furthermore, we estimated the percentage of activity
impairment due to chronic pain for all participants.
Analysis
We used a panel data analytic approach to analyse the
effect of pain duration on health care prescription drug use.
That is to say, we calculated participant individual annual
health care and prescription drug use costs from 1995 to
2005. This data was combined with information relating to
how many years the participant had suffered from chronic
pain. Thus, each participant produced ten observations.
For participants that had suffered from pain for exactly
10 years, the first observation (i.e. 1995) would be the first
year with pain, the second observation the second year and
so on. For participants that had suffered from pain for less
than 10 years, some observations were for years before
pain onset. For patients that had suffered from chronic pain
for more than 10 years, pain onset was before 1995.
Thus, the ten observations per participant covered a time
span from 0 to 9 years with chronic pain, over a time span
from 40 to 50 years with chronic pain, and down to -9 to
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1 year with chronic pain (negative values indicating time in
which the participant did not suffer from chronic pain).
We used pooled ordinary least squares (OLS) regres-
sion, and fixed and random effects models to explore how
pain duration affected annual health care and prescription
drug use costs.
The pooled OLS model was estimated using ordinary
least squares on the cross-sectional time-series data for all
individuals. It was assumed that all individual-specific
effects were constant and equal across the participants, i.e.
it assumed heterogeneity across participants. Thus, only a
single overall intercept was estimated. This assumption
was relaxed using the fixed effect model, which captured
individual specific effects that do not change over time.
In the random effects model, the individual specific
effects were treated as randomly distributed. However, it
was assumed that the individual effects were uncorrelated
with other independent variables in the model.
Participant age and gender were used as independent
variables. Pain duration was included as a categorical
variable to capture non-linear effects on health care and
prescription drug costs. That is to say, pain duration was
included as dummy variables, with a value of 0 or 1. A
variable that equalled 1 was used if the observation con-
sidered related to the year before pain onset (otherwise the
variable equalled 0), another variable equal to 1 was used if
the participant had suffered from pain over a period of up
to 1 year, and a third variable equal to 1 if the participant
had suffered from pain between 1 and 2 years, and so forth.
However, pain duration above 5 years was categorised in
5-year intervals. For example, a variable that equalled 1
was used if the participant had suffered from chronic pain
for between 5 and 10 years.
The dummy variables measured the differences in health
care costs and prescription drug costs over a particular time
and reference period, namely the 1-9 years before pain
onset.
We successively tested whether the pain duration coef-
ficients relating to the dummy variables differed and, as the
coefficients for the remaining dummies were not statisti-
cally different from each other, ended up including only
three dummy variables for pain duration in the regression
analyses of health care costs and only two in the regression
analyses of prescription drug costs.
The variables for age, gender, and pain duration con-
stituted the main effects of the model. Because of the
dummy variables, coefficients referred to a reference per-
son, namely a male with 1 year or more since pain onset.
Furthermore, we included year dummies for 1996 to
2005 in order to capture the fact that the population may
have different distributions in different time periods [23].
However, the first dummy variable for year 1996 was left
out, i.e. the year 1996 was used as a reference.
A Hausmann test was used to compare random and fixed
effects estimators [23].
Results
Participant characteristics
A total of 298 patients were on the waiting list for treat-
ment at The Multidisciplinary Pain Clinic in Funen County
at Odense University Hospital. Of these, 94 patients were
not included in the study: 14 because the sample size target
was met, 22 who did not give consent, 21 were not at home
when contacted, 5 due to non-fluency in Danish, 11 were
not listed in the telephone lists, 6 were withdrawn from the
waiting list, and 15 were not included due to other reasons.
This left 204 participants for the study.
Table 1 shows participant pain characteristics. The
majority of participants were females (61%). At the time of
the telephone interview, they were between 20 and 89 years
of age, with a mean age of 48.1 years (SD = 13.74). The
enrolled patients did not differ on age or gender from those
patients that were not included in the study.
Table 1 Pain characteristics of the participants. Figures represent
number of persons with percentages in parenthesis (n = 204)
Pain location
Head, neck, shoulders, arms 114 (56%)
Thorax 10 (5%)
Abdomen 18 (9%)
Lower back and legs 122 (60%)
Pain diagnosis
Neuropathic 56 (28%)
Vescical 24 (12%)
Muscles, bones, joint, connective tissue 163 (80%)
Skin (nociceptive pain) 2 (1%)
Unknown 6 (3%)
Aetiology
Congenital 5 (3%)
Trauma, operation, burn 67 (33%)
Degeneration 81 (40%)
Infection, inflammation 9 (4%)
Other/inexplicable 79 (39%)
Pain duration (years)
0–4 65 (32%)
5–9 50 (25%)
10–14 25 (12%)
15–19 18 (9%)
20–24 20 (10%)
25–29 11 (5%)
30–39 10 (5%)
[40 5 (3%)
8 C. Kronborg et al.
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Participants reported that they had suffered from chronic
pain from between 6 months and up to 50 years with an
average of 11.4 years (SD = 10.06; median 7.5 years).
Female participants had suffered from chronic pain for
3.6 years more than male participants (95% confidence
interval: 0.9–6.2).
Consequently, female participants were younger than
male participants at pain onset: the female participants
were on average 34.7 years old (SD = 14.77), whereas
male participants were 40.5 years old (SD = 15.16;
P = 0.0045).
The most frequent pain location was in the lower back,
head, neck, shoulders or arms. The most frequent pain
diagnoses were nociceptive pain in muscles, bones, joints
or connective tissue. Pain was mainly caused by degener-
ation, and trauma, operation, or burns. However, pain
aetiology in many participants was unknown.
Health care costs
Table 2 shows the results from the regression analyses of
annual health care costs in relation to age, gender, and pain
duration.
The Hausman specification test found no statistically
significant difference between the random effects and fixed
effects estimates, and thus no conclusive evidence as to
whether the fixed or random effects estimates were
preferred.
Whereas gender did not affect annual health care costs,
annual health care costs increased with age by about
DKK 560 per person per year according to the pooled OLS
and random effects models, and by about DKK 800 per
person per year according to the fixed effects model.
The annual health care costs were higher in years after
pain onset than before pain onset. Furthermore, health care
costs were higher in the year before reported pain onset
than in previous years, i.e. 9 to 2 years before pain onset.
The pooled OLS model suggested that the annual health
care costs in the year prior to pain onset were DKK 8,699
per person higher than in previous years. However, at a 5%
level of significance in the fixed and random effects models
the coefficient to this variable was not significant.
In the year in which participants reported pain onset, the
annual health care costs were about DKK 17,500 per per-
son higher than health care cost in the period 2 to 9 years
prior to pain onset. The exact figure depended on the
regression model.
In years where the participants had suffered from
chronic pain for more than 1 year, the annual health care
costs were about DKK 8,000 per person higher than in
years prior to pain onset. However, at a 5% level of
Table 2 Regression of annual health care costs on gender, age, and pain duration (number of observations = 2,040; number of groups = 204)
Pooled OLS Random effects (RE) Fixed effects (FE)
Coefficient SE P Coefficient SE P Coefficient SE P
Female 411 2,151 0.849 465 3,932 0.906 – – –
Age 560 91 0.000 562 140 0.000 806 526 0.125
Duration
-1 to 0 years 8,699 4,013 0.030 8,456 4,451 0.057 8,290 4,507 0.066
0 to 1 year 18,421 5,702 0.001 17,519 4,315 0.000 17,117 4,426 0.000
1 year or more 8,715 1,846 0.000 8,094 3,434 0.018 7,597 4,099 0.064
d97 -1678 3,468 0.629 -1682 4,093 0.681 -1,908 3,881 0.623
d98 -2572 3,691 0.486 -2435 4,096 0.536 -2,984 3,714 0.422
d99 -1911 3,611 0.597 -1845 4,140 0.656 -2,511 3,614 0.487
d00 -3391 4,050 0.403 -3268 4,176 0.434 -4,144 3,555 0.244
d01 1,877 3,759 0.618 2,041 4,268 0.632 962 3,564 0.787
d02 1,937 4,157 0.641 2,176 4,376 0.619 900 3,632 0.804
d03 16,543 5,950 0.005 16,842 4,491 0.000 15,370 3,735 0.000
d04 16,245 5,885 0.006 16,569 4,588 0.000 14,886 3,878 0.000
d05 1,598 4,389 0.716 1,914 4,670 0.682 – – –
Constant -9,032 4,141 0.029 -8,838 7,008 0.207 -17,778 21,490 0.408
R2 0.0729 0.0729 0.0704
Root MSE 47,476
Specification test
Hausman test for RE versus FE V2(12) = 0.69; P = 1.000
OLS ordinary least squares
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significance the coefficient was not statistically significant
in the fixed effects model.
Prescription drugs
Table 3 shows the results of regression analyses of annual
prescription drug costs in relation to gender, age, and pain
duration. Gender did not influence the costs, whereas
annual prescription drug costs increased with age. How-
ever, at a 5% level of significance, the coefficients to the
variables for pain duration were not statistically significant,
except for the coefficient for pain duration for more than
1 year, in the pooled OLS model, which suggested that
prescription drugs costs were DKK 2,466 per person higher
compared with drug consumption costs in years prior to
pain onset.
Council services
A total of nine participants (4%) reported that they received
council personal services (e.g. personal care, dressing,
medication). Furthermore, 26 participants (13%) reported
that they received council housekeeping and gardening
services.
Use of personal care services and housekeeping and
gardening services was decidedly skewed. Recipient use of
personal care varied between 2 and 450 h per month.
Leaving out the participant in receipt of 450 h personal
care per month, the average amount of personal care was
35.4 h per recipient per month (SD = 33.02).
Recipient use of housekeeping and gardening services
ranged from between 1 and 56 h per month, averaging
6.8 h per recipient per month (SD = 11.20).
Recipients had received council services and support for
between 0 and 13 years at the time of the interview, with
an average of 3.2 years per recipient (SD = 3.58). Recip-
ients had started receiving council services and support
between 1 and 48 years after pain onset. On average, they
started receiving help after 14.2 years after pain onset
(SD = 13.13).
Table 4 shows the average cost of council services with
a sensitivity analysis since unit costs of services vary
between municipalities in Denmark.
Privately provided services
Seventy eight (38%) of the participants reported that they
had paid for private housekeeping services and gardening.
Two participants reported that they had procured these
services before pain onset. The remaining participants had
Table 3 Regression of annual costs of prescription drug use on gender, age, and pain duration (number of observations = 1,740; number of
groups = 174)
Pooled OLS Random effects (RE) Fixed effects (FE)
Coefficient SE P Coefficient SE P Coefficient SE P
Female 116 578 0.841 361 1,236 0.770 – – –
Age 269 29 0.000 277 43 0.000 1,144 120 0.000
Pain duration
0 to 1 year 42 638 0.948 -768 993 0.440 -1,116 1,002 0.266
1 year or more 2,466 463 0.000 131 794 0.869 -839 879 0.340
d97 -295 638 0.644 -181 959 0.850 -998 907 0.272
d98 -106 693 0.879 58 961 0.952 -1,600 869 0.066
d99 -501 688 0.466 -235 968 0.808 -2,715 844 0.001
d00 -442 740 0.550 -60 980 0.951 -3,353 831 0.000
d01 143 799 0.858 699 998 0.484 -3,387 830 0.000
d02 458 822 0.577 1,206 1,024 0.239 -3,663 844 0.000
d03 407 837 0.626 1,385 1,057 0.190 -4,252 869 0.000
d04 701 871 0.421 1,864 1,091 0.087 -4,559 907 0.000
d05 5,956 2,086 0.004 7,238 1,119 0.000 – – –
Constant -8455 1,315 0.000 -7,992 2,128 0.000 -41,181 4,990 0.000
R2 0.1510 0.1452 0.1146
Root MSE 11,578
Specification test
Hausman test for RE verses FE V2(11) = 6.67; P = 0.8251
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suffered from pain for an average of 7.7 years before they
started procuring privately provided services (SD = 9.76).
At the time of the telephone interview, they had procured
these services for an average of 4.5 (SD = 5.75) years per
person.
Forty one (20%) had paid for such services within
6 months of the telephone interview. Reported expenditure
was between DKK 90 and DKK 75,000. The average
annual cost for privately provided services due to chronic
pain was estimated at DKK 12,408 per participant
(SD = 67,356).
Alternative treatment
Out of 166 participants that returned the mailed question-
naire, 131 (79%) reported that they had been treated by
therapists outside the general health service (alternative
treatment). Table 5 shows the various types of therapists
contacted by participants as a result of chronic pain.
Eight (4%) participants on the mailed questionnaire had
contact with one or more alternative therapists before pain
onset. Those that contacted alternative therapists after pain
onset initiated alternative treatment between 0 and 40 years
after pain onset. The average number of years between pain
onset and contact to alternative therapists was 6.3 years per
person (SD = 7.92).
Annual expenditure by users on alternative treatment
was between DKK 300 and DKK 30,300. Thus, average
expenditure on alternative treatment was DKK 2,978 per
participant per year (SD = 5,347).
Production costs
A total of 47 (29%) participants reported they were cur-
rently employed. Table 6 shows the WPAI instrument
results. On average, chronic pain meant that participants in
work missed 19.4% of the time they could have worked
(SD = 32.93). During the time they actually worked,
productivity was reduced by an average of 51.1 (SD =
23.49), i.e. 31 min of every hour were not productive due
to chronic pain. Out of the total number of work hours
available to the respondent, 41.0% were lost due to chronic
pain (SD = 23.00).
All participants were asked about their ability to carry
out non-work activities such as housekeeping, childcare,
and studying. On average, they were impaired by 71.0%
(SD = 20.74), i.e. for every hour available for non-work
activities, 42 min were lost due to chronic pain.
Discussion
This study shows that health care costs due to chronic pain
are particular high during the first year after pain onset, and
that the health care costs remain high compared with
chronic pain patients’ health care cost before pain onset.
There is no conclusive evidence that chronic pain increases
the costs of prescription drugs.
This study also shows that chronic pain causes produc-
tion losses and impairment in non-work activities such as
housekeeping, childcare, and studying.
An important strength of this study is that it relies on
data from public registers relating to the use of health care
services and prescription drugs. These types of registers
Table 4 Mean cost of council personal care, housekeeping and gardening services in Danish kroner (DKK) per participant per year. n = 204
(figures in parentheses represent standard deviation)
Service Applying council
specific unit costs
Sensitivity analysisa
Applying lowest
observed unit cost
Applying highest
observed unit costs
Personal care 12,468 (110,172) 9,444 (86,028) 14,964 (136,296)
Housekeeping, gardening, etc. 2,592 (144,544) 2,136 (11,376) 3,348 (17,844)
Total 15,060 (111,312) 11,568 (86,916) 18,300 (137,688)
a The sensitivity analysis shows how the estimated cost changed when using unit costs applicable to different Danish councils
Table 5 Use of treatments outside the general health service system
(alternative treatments) at any time due to chronic pain. The figures
represent the number of persons who have used the service (figures in
parentheses represent percentages). n = 166
Natural medicinal products (e.g. homeopathy) 36 (22%)
Reflexology 51 (31%)
Relaxation 37 (22%)
Instruction regarding diet, exercise etc. 34 (24%)
Acupuncture 71 (43%)
Touching 9 (5%)
Massage/manipulation 70 (42%)
Use of apparatus (e.g. magnetic passes) 8 (5%)
Healing 39 (24%)
Hypnosis 6 (4%)
Other 52 (31%)
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generally have a high degree of completeness and validity
[1, 10, 11, 14]. However, register data considers treatment
practice at the time the service was provided to the patient,
which may differ from contemporary treatment practice,
i.e. treatment provided in 1996 may differ from treatment
provided in 2006. Furthermore, technology and produc-
tivity may change over time. Thus, cost estimates due to
chronic pain in this study may be affected by these factors.
Caution should be exercised when using these estimates in
further analyses on the influence of interventions to prevent
or treat chronic pain. Furthermore, over-the-counter drugs,
and some prescription drugs not subject to reimbursement,
are not recorded in the prescription register.
Another limitation of the study is that it relies on
information that may be affected by recall bias. Patients
may have had difficulty in specifying the exact time of pain
onset. Recall bias may have caused the finding that the
health care costs increased the year before pain onset. In
addition, recall bias may also have influenced the cost
estimates relating to publicly and privately provided non-
health care services and alternative treatments.
The results of regression analyses show that only a
minor part of the variation in health care costs and pres-
cription drug costs could be explained by gender, age, and
pain duration. A limitation of the study is that several
factors that might explain additional variation are not
observable, for example information about diagnostics,
during the same period as that covered by the data.
The results of the regression analyses of health care
costs showed very high cost increases in 2003 and 2004.
We have explored the data for potential extreme observa-
tions. However, we did not find any such observations that
may have affected the results.
Whereas the analyses showed consistent results on the
effects of pain duration on health care costs, the conse-
quences of pain duration on prescription drug costs
changed in the various regression models. The statistically
significant effect of pain duration of 1 year or more on
prescription drug costs in the pooled OLS model may be
caused by individual effects. This individual effect is
accounted for in the random effects and fixed effects
models.
Several cost-of-illness studies of pain have been pub-
lished, e.g. [4, 7, 8, 22]. Compared with previous studies,
we consider the cost of chronic pain in general, not pain
due to specific pathophysiology or aetiology. Furthermore,
this study differs from cost-of-illness studies in their tra-
ditional form, in that we have not sought to estimate the
total cost of chronic pain in the total Danish patient
population.
The results of this study cannot be used in a priority
setting, because assessments of the health benefits of the
resources allocated to treatment of patients have not been
included. However, the cost estimates may be useful in an
economic evaluation that considers the cost-effectiveness
of treating chronic pain patients in a multidisciplinary pain
clinic. Based on the results of this study, evidence of cost-
effectiveness of chronic pain interventions would be
expected if an intervention is capable of reducing health
care consumption rather than prescription drug use.
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Appendix
More information about work productivity and activity
impairment (WPAI) instruments is available from (April
2007):
http://www.reillyassociates.net/Index.html.
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